Rôle de la TEP/TDM dans la prise en charge des lymphomes de Hodgkin
You don't have permission to view the content
Biologie du lymphome de Hodgkin classique : quelles implications cliniques ?
You don't have permission to view the content
La commission Hodgkin du LYSA
You don't have permission to view the content
Repenser la protection des patients hémophiles
You don't have permission to view the content
La thérapie génique dans l’hémophilie : évolution du parcours multidisciplinaire centré sur le patient.
You don't have permission to view the content
slam session
You don't have permission to view the content
HOT TOPICS SESSION
You don't have permission to view the content
Pratique clinique
You don't have permission to view the content
Traitements futurs
You don't have permission to view the content
Pourquoi les Centres de Maladies Hémorragiques ont besoin d’un hépatologue ?
You don't have permission to view the content
French 
English 